Date Range
Date Range
Date Range
ADDIS 2 release 14 improves benefit-risk analysis, both stand-alone and in the main ADDIS app.
Progress and Activity Report 2016. European Organisation for Research and Treatment of Cancer. Ongoing and future clinical trials. Many women with early breast cancer have a very low risk of a locoregional recurrence five years after surgery. News from European Breast Cancer Conference. Clinical Trial Statistics for Non Statisticians. 12 Jun - 15 Jun 2018.
Within the EMIF-platform topic, research into a broad range of aspects dealing with re-use of health data will be addressed. Will address issues critical to the use of large datasets especially those dealing with personal health data, including semantic interoperability as well as ethics and data privacy and it will include the development of an IT platform.
Kje ob zmagovalnem sosedu je moja priložnost? To velja za vsakega posameznika, kot tudi za vse nas, ki živimo v slovenski državni skupnosti. A če sprememb ne zmoremo izpeljati pri sebi osebno, kako neki jih bomo skupaj? Tam v resnici vedo, da se s tiščanjem na bremzo ne pride prav daleč. Nimam več ničesar, vse sem razdeli.
Naša spletna stran uporablja piškotke. Zato da omogočamo naročanje in klepet. Strinjam se z uporabo piškotkov.
Decision analysis for drug benefit-risk assessment. Is designed to help policy makers and researchers judge the balance of favorable and unfavorable effects of medicines. This tool is intended to be part of the ADDIS 2. Decision support system for health care policy.
O paradajzih, življenju, fotografiji, tehnologiji, vesolju in sploh vsem. Vedno imam probleme z iskenjem parov nogavic. Zato sem začel nosti tudi različne nogavice skupaj v paru. Kar je sicer lahko zabavno. No im potem se ena brihtna glava spomne in naredi škatlo s sedmimi nagavicami, ki so si vse oblikovalsko podobne in jih lahko zamešaš in nosiš kakor hočeš, tudi če si stonoga. In da se ideja bolje prime, ponudi nogavice na Kickstarteju.